209 related articles for article (PubMed ID: 12324718)
1. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society.
Clayton PE; Miller WL; Oberfield SE; Ritzén EM; Sippell WG; Speiser PW;
Horm Res; 2002; 58(4):188-95. PubMed ID: 12324718
[No Abstract] [Full Text] [Related]
2. Regarding the consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.
Creighton S; Ransley P; Duffy P; Wilcox D; Mushtaq I; Cuckow P; Woodhouse C; Minto C; Crouch N; Stanhope R; Hughes I; Dattani M; Hindmarsh P; Brain C; Achermann J; Conway G; Liao LM; Barnicoat A; Perry L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3455; author reply 3456. PubMed ID: 12843205
[No Abstract] [Full Text] [Related]
3. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.
Joint LWPES/ESPE CAH Working Group.
J Clin Endocrinol Metab; 2002 Sep; 87(9):4048-53. PubMed ID: 12213842
[No Abstract] [Full Text] [Related]
4. Management of congenital adrenal hyperplasia: results of the ESPE questionnaire.
Riepe FG; Krone N; Viemann M; Partsch CJ; Sippell WG
Horm Res; 2002; 58(4):196-205. PubMed ID: 12324719
[TBL] [Abstract][Full Text] [Related]
5. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Horm res 2002;58:188-195.
Creighton S
Horm Res; 2003; 59(5):262. PubMed ID: 12714792
[No Abstract] [Full Text] [Related]
6. Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia.
Speiser PW
Horm Res; 2007; 68 Suppl 5():90-2. PubMed ID: 18174718
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of classical congenital adrenal hyperplasia.
Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
[TBL] [Abstract][Full Text] [Related]
8. Description and defense of prenatal diagnosis and treatment with low-dose dexamethasone for congenital adrenal hyperplasia.
New M
Am J Bioeth; 2010 Sep; 10(9):48-51. PubMed ID: 20818561
[No Abstract] [Full Text] [Related]
9. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Fujieda K; Mukai T
Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
[TBL] [Abstract][Full Text] [Related]
10. Prenatal treatment of congenital adrenal hyperplasia. The United States experience.
New MI
Endocrinol Metab Clin North Am; 2001 Mar; 30(1):1-13. PubMed ID: 11344929
[TBL] [Abstract][Full Text] [Related]
11. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.
Speiser PW; Arlt W; Auchus RJ; Baskin LS; Conway GS; Merke DP; Meyer-Bahlburg HFL; Miller WL; Murad MH; Oberfield SE; White PC
J Clin Endocrinol Metab; 2018 Nov; 103(11):4043-4088. PubMed ID: 30272171
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
13. Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.
Pediatrics; 2000 Dec; 106(6):1511-8. PubMed ID: 11099616
[TBL] [Abstract][Full Text] [Related]
14. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment.
Nimkarn S; New MI
Ann N Y Acad Sci; 2010 Mar; 1192():5-11. PubMed ID: 20392211
[TBL] [Abstract][Full Text] [Related]
15. [Prenatal diagnosis of congenital adrenal hyperplasia and possibilities of prenatal therapy].
Snajderová M; Kolousková S
Cesk Pediatr; 1992 Aug; 47(8):497-9. PubMed ID: 1394557
[No Abstract] [Full Text] [Related]
16. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.
Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
Nimkarn S; New MI
Horm Res; 2007; 67(2):53-60. PubMed ID: 17047340
[TBL] [Abstract][Full Text] [Related]
18. [21 hydroxylase deficiency: new strategies emerging from molecular studies].
Morel Y; Tardy V; Costa JM; Forest MG; David M
Ann Endocrinol (Paris); 2003 Dec; 64(6):456-70. PubMed ID: 15067252
[No Abstract] [Full Text] [Related]
19. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Glatt K; Garzon DL; Popovic J
J Spec Pediatr Nurs; 2005; 10(3):104-14. PubMed ID: 16083430
[TBL] [Abstract][Full Text] [Related]
20. How can molecular biology contribute to the management of congenital adrenal hyperplasia?
Ritzén EM; Lajic S; Wedell A
Horm Res; 2000; 53 Suppl 1():34-7. PubMed ID: 10895040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
